Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1603466 STAMFORD, CT
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$275,730
+$181,142 QoQ
Shares Held
52,520
+106.6% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 98 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. LFCR ranks #19 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 201,159 $108,993,980
2 HLN
Haleon plc
 9,264,255 $86,435,499
3 LNTH
Lantheus Holdings, Inc.
 629,806 $69,870,677
4 INDV
Indivior Pharmaceuticals, Inc.
 1,250,639 $51,313,718
5 KNSA
Kiniksa Pharmaceuticals International, plc
 659,493 $42,174,577
6 TEVA
Teva Pharmaceutical Industries Ltd
 1,059,778 $35,905,278
7 BHC
Bausch Health Companies Inc.
 2,235,821 $11,022,597
8 EOLS
Evolus, Inc.
 1,508,518 $10,469,114

All Filings in LFCR

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $275,730 52,520
2026-03-31 $94,588 25,427
2025-12-31 $128,066 15,656
2022-12-31 $916,570 141,446
2022-09-30 $1,655,353 186,204
2022-06-30 $2,030,889 203,700
2022-03-31 $3,028,818 261,556
2021-12-31 $1,964,910 177,019